191 related articles for article (PubMed ID: 12861385)
1. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts.
Sarker KP; Maruyama I
Cell Mol Life Sci; 2003 Jun; 60(6):1200-8. PubMed ID: 12861385
[TBL] [Abstract][Full Text] [Related]
2. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
Liao YS; Wu J; Wang P; Zhang H
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
[TBL] [Abstract][Full Text] [Related]
3. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
4. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
[TBL] [Abstract][Full Text] [Related]
5. Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.
Movsesyan VA; Stoica BA; Yakovlev AG; Knoblach SM; Lea PM; Cernak I; Vink R; Faden AI
Cell Death Differ; 2004 Oct; 11(10):1121-32. PubMed ID: 15375383
[TBL] [Abstract][Full Text] [Related]
6. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
[TBL] [Abstract][Full Text] [Related]
7. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
[TBL] [Abstract][Full Text] [Related]
8. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
[TBL] [Abstract][Full Text] [Related]
9. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
10. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
[TBL] [Abstract][Full Text] [Related]
11. ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death.
Sarker KP; Biswas KK; Yamakuchi M; Lee KY; Hahiguchi T; Kracht M; Kitajima I; Maruyama I
J Neurochem; 2003 Apr; 85(1):50-61. PubMed ID: 12641726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Felder CC; Joyce KE; Briley EM; Mansouri J; Mackie K; Blond O; Lai Y; Ma AL; Mitchell RL
Mol Pharmacol; 1995 Sep; 48(3):443-50. PubMed ID: 7565624
[TBL] [Abstract][Full Text] [Related]
13. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
Derocq JM; Bouaboula M; Marchand J; Rinaldi-Carmona M; Ségui M; Casellas P
FEBS Lett; 1998 Apr; 425(3):419-25. PubMed ID: 9563506
[TBL] [Abstract][Full Text] [Related]
14. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
[TBL] [Abstract][Full Text] [Related]
15. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of anandamide at recombinant and endogenous rat vanilloid receptors.
Jerman JC; Gray J; Brough SJ; Ooi L; Owen D; Davis JB; Smart D
Br J Anaesth; 2002 Dec; 89(6):882-7. PubMed ID: 12453933
[TBL] [Abstract][Full Text] [Related]
17. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
[TBL] [Abstract][Full Text] [Related]
18. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
19. Anandamide induces cough in conscious guinea-pigs through VR1 receptors.
Jia Y; McLeod RL; Wang X; Parra LE; Egan RW; Hey JA
Br J Pharmacol; 2002 Nov; 137(6):831-6. PubMed ID: 12411414
[TBL] [Abstract][Full Text] [Related]
20. Dual effect of cannabinoid CB1 receptor stimulation on a vanilloid VR1 receptor-mediated response.
Hermann H; De Petrocellis L; Bisogno T; Schiano Moriello A; Lutz B; Di Marzo V
Cell Mol Life Sci; 2003 Mar; 60(3):607-16. PubMed ID: 12737320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
